About Retero life sciences
Retero life sciences is a Healthcare company based in Hyderabad (India) founded in 2018. Functions as a CDMO focused on API intermediates manufacturing. It operates on a B2B model. Its Indian entity Retero Life Sciences Private Limited reported revenue of ₹1.80 Cr. Its focus areas include Pharmaceuticals, Manufacturing and API Intermediates. Its competitors include Viyash, Inventys and Blue Jet Healthcare; 2 of its 3 listed competitors have raised funding.
Company details
Retero life sciences functions as a cdmo focused on api intermediates manufacturing through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api intermediates. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Website reterolifesciences.com
- Legal Name Retero Life Sciences Private Limited
- Date of Incorporation 17 Jan, 2018
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹1.80 Cr
FY 2023 · -55% YoY
- Net Profit₹4.9 Lakh
FY 2023 · 3% margin
- EBITDA₹7.1 Lakh
FY 2023 · 4% margin
Associated legal entities of Retero life sciences
Retero life sciences operates through Retero Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Retero Life Sciences Private Limited CIN U24304TG2018PTC121898 | Active | 17 Jan 2018 | Hyderabad, Telangana | ₹1.8 Cr | 2 | View details |
Board of directors of Retero Life Sciences Private Limited (Retero life sciences)
Retero Life Sciences Private Limited is the primary company behind Retero life sciences. The board of Retero Life Sciences Private Limited currently have 2 directors; the longest-serving is Sambasivarao Narra, appointed in 2019. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sambasivarao Narra DIN 08511023 | Director | 16 Jul 2019 | 7 yrs 3 mo | Retero Life Sciences Private Limited |
| Narra Kavitha DIN 09567726 | Director | 15 Apr 2022 | 4 yrs 6 mo | Retero Life Sciences Private Limited |
Financials of Retero life sciences
Figures of Retero Life Sciences Private Limited, the primary company behind Retero life sciences, for FY 2023. Revenue was ₹1.80 Cr (-55% year on year). Net profit was ₹4.9 Lakh (3% margin). EBITDA was ₹7.1 Lakh (4% margin). Revenue has grown at a compounded annual rate of +24% over three years.
- ₹1.80 CrRevenue · FY 2023 · -55% YoY
- ₹4.9 LakhNet profit · 3% margin
- ₹7.1 LakhEBITDA · 4% margin
- ₹1 LakhPaid-up capital
- +24%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Retero Life Sciences Private Limited are on its company page.
Detailed financial statements for Retero life sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Retero life sciences
Retero life sciences has 3 listed competitors in our database, 2 of them funded. They include Viyash, Inventys and Blue Jet Healthcare.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viyash.com | 2019 | Hyderabad, India | $120.02M | 277 | APIs and intermediates are manufactured by Viyash as a CDMO. | |
| inventys.in | 2005 | Mumbai, India | $64.34M | 219 | Actives, advanced intermediates, and specialty chemicals are custom manufactured. | |
| bluejethealthcare.com | 1969 | Mumbai, India | 476 | CDMO focused on manufacturing, supplier, and development of intermediates & APIs |
Detailed competitors of Retero life sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Retero life sciences
Retero life sciences was founded in 2018.
Retero life sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Retero life sciences, Retero Life Sciences Private Limited, reported revenue of ₹1.80 Cr for FY 2023, down 55% year on year.
Retero life sciences functions as a cdmo focused on api intermediates manufacturing through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api intermediates. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Retero life sciences's top competitors include Inventys, Viyash and Blue Jet Healthcare.
Retero life sciences operates through Retero Life Sciences Private Limited.
The legal entities of Retero life sciences currently have 2 directors, including Sambasivarao Narra, Narra Kavitha.